Skip to content
value.today

Autobio Diagnostics Co., Ltd. vs CareDx, Inc

Add a company

Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.

In short

  • CareDx, Inc is the larger company by market value: $3.4 B against $2.9 B for Autobio Diagnostics Co., Ltd., 1.1 times as much (market caps of Aug 1, 2026 for Autobio Diagnostics Co., Ltd. and Oct 19, 2026 for CareDx, Inc). Autobio Diagnostics Co., Ltd.'s value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.
  • Autobio Diagnostics Co., Ltd. had more revenue: $548 M in the year to December 2021 against $380 M for CareDx, Inc in the year to December 2025.
  • Autobio Diagnostics Co., Ltd. made a net profit of $142 M, while CareDx, Inc made a net loss of $21 M.
  • Autobio Diagnostics Co., Ltd. keeps more of each dollar of sales: a net margin of 25.9% against -5.6% for CareDx, Inc.
  • On price to earnings, CareDx, Inc trades at 26.1× and Autobio Diagnostics Co., Ltd. at 20.7×: investors pay more for each dollar of CareDx, Inc's profit.

Market value, the same start = 100

From Jan 2020: how each one's value moved, whatever its size.

045891341792020202120222023202420252026Autobio Diagnostics Co., Ltd. 52CareDx, Inc 101

Revenue by fiscal year

US$ billions, as reported in each year's annual results.

$0B$0B$0B$0B$0B201720182019202020212022202320242025CareDx, Inc $0B

Side by side

Side-by-side comparison; ▲ marks the best value of a measure where higher or lower is better
MeasureAutobio Diagnostics Co., Ltd.
603658.SS · #5,082 in the world
CareDx, Inc
CDNA · #4,672 in the world
Profile
Country🇨🇳 China🇺🇸 USA
SectorHealthcareHealthcare
IndustryDiagnostics and ResearchDiagnostics and Research
Founded19991998
Size
Market cap$2.9 B$3.4 B
Revenue$548 M$380 M
Net income$142 M▲ best$-21 M
Employees—645
Valuation
P/E ratio20.7×26.1×
Price to sales5.4×6.8×
Price to book2.7×11.1×
Free cash flow yield—-0.2%
Profitability
Operating margin—-8.1%
Net margin—-5.6%
Return on equity—-6.3%
Growth
Revenue growth—13.8%
Revenue growth, 3 years a year—5.7%
Shareholder returns
Shareholder yield—2.6%
Altman Z-score zone—safe
Data as ofMarket cap Aug 2026Market cap Oct 2026; ratios FY2025

▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither

Questions and answers#

Which is bigger, Autobio Diagnostics Co., Ltd. or CareDx, Inc?

CareDx, Inc is the larger company by market value: $3.4 B against $2.9 B for Autobio Diagnostics Co., Ltd., 1.1 times as much (market caps of Aug 1, 2026 for Autobio Diagnostics Co., Ltd. and Oct 19, 2026 for CareDx, Inc). Autobio Diagnostics Co., Ltd.'s value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.

Which makes more money, Autobio Diagnostics Co., Ltd. or CareDx, Inc?

Autobio Diagnostics Co., Ltd. had more revenue: $548 M in the year to December 2021 against $380 M for CareDx, Inc in the year to December 2025. Autobio Diagnostics Co., Ltd. made a net profit of $142 M, while CareDx, Inc made a net loss of $21 M.

Which is more profitable, Autobio Diagnostics Co., Ltd. or CareDx, Inc?

Autobio Diagnostics Co., Ltd. keeps more of each dollar of sales: a net margin of 25.9% against -5.6% for CareDx, Inc.

Is Autobio Diagnostics Co., Ltd. cheaper than CareDx, Inc?

On price to earnings, CareDx, Inc trades at 26.1× and Autobio Diagnostics Co., Ltd. at 20.7×: investors pay more for each dollar of CareDx, Inc's profit. A lower multiple is not by itself a better buy: it also reflects expected growth, risk and accounting.

Sources#

Every figure on this page comes from these, with the date shown next to it.